News
Street Calls of the Week ...
Imexpharm Pharmaceutical JSC (IMP) has reported a strong profit rebound in the second quarter of 2025, driven mainly by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback